Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01078493

Wrinkle Injection With Autologous Platelet Rich Plasma Study

Phase 1 Study of Intradermal Injection of Autologous Platelet Rich Plasma for Facial Wrinkles

Status
Withdrawn
Phase
Phase 1
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Novena Medical Center · Network
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

Wrinkles result from imperfect repair of the dermal layer resulting in loss of collagen commonly due to ageing, smoking and sun exposure. Platelet rich plasma (PRP) contains a host of growth factors, which have been used in other clinical trials for various medical conditions such as tendonitis, and also in surgery such as the surgical repair of facial defects. Results from these clinical trials suggest that PRP helps in collagen formation and organisation to promote healing of tissues. This study attempts to document the clinical effects of intradermal injection of PRP on wrinkles.

Detailed description

10 selected participants will have 10 ml of blood removed for platelet extraction with MyCells®. The resulting Platelet rich plasma will be injected intradermally into the facial wrinkles.

Conditions

Interventions

TypeNameDescription
DEVICEMyCells® (injection of platelet rich plasma)PRP contains at least 1,000,000 platelets per mm3 or 2-6 times the native concentration of whole blood at a pH of 6.5 to 6.7

Timeline

Start date
2010-02-01
Primary completion
2012-02-01
Completion
2012-05-01
First posted
2010-03-02
Last updated
2016-09-26

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT01078493. Inclusion in this directory is not an endorsement.